(Q24632792)

12

0 references

Jeffrey B. Kopp

object named as

Jeffrey B Kopp

8

0 references

Napoleone Ferrara

12

object named as

Napoleone Ferrara

0 references

author name string

Vera Eremina

1

0 references

J Ashley Jefferson

2

0 references

Jolanta Kowalewska

3

0 references

Howard Hochster

4

0 references

Mark Haas

5

0 references

Joseph Weisstuch

6

0 references

Catherine Richardson

7

0 references

M Golam Kabir

9

0 references

Peter H Backx

10

0 references

Hans-Peter Gerber

11

0 references

Laura Barisoni

13

0 references

Charles E Alpers

14

0 references

Susan E Quaggin

The New England Journal of Medicine

15

0 references

language of work or name

English

0 references

publication date

13 March 2008

0 references

published in

0 references

volume

358

0 references

issue

11

0 references

page(s)

1129-36

0 references

cites work

VEGF(165) mediates glomerular endothelial repair

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Vascular endothelial growth factor trap in non small cell lung cancer

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Mice expressing a humanized form of VEGF-A may provide insights into the safety and efficacy of anti-VEGF antibodies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Nephrotic syndrome after bevacizumab: case report and literature review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Glomerular endothelial cell differentiation.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Urinary Placental Growth Factor and Risk of Preeclampsia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Circulating angiogenic factors and the risk of preeclampsia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Effects of filtration rate on the glomerular barrier and clearance of four differently shaped molecules

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030578

Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18337603

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Thrombotic microangiopathy and anti-VEGF agents

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18337603

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Contribution of the endothelium to the glomerular permselectivity barrier in health and disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18337603